Cases & Deals

  • Home
  • Practices
  • Genemed Biotechnologies sold to Sakura Finetek USA

Share

Genemed Biotechnologies sold to Sakura Finetek USA

December 2015

Client(s) Genemed Biotechnologies, Inc.

Jones Day advised Genemed Biotechnologies, Inc., a leading designer and manufacturer of immunohistochemical reagents for in vitro diagnostics, in its stock sale to Sakura Finetek USA, Inc., a global designer and manufacturer of histology equipment for pathologic laboratory use. The transaction combines two complementary companies into an innovative contributor to the advancement of immunohistochemistry and histology research and applications.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.